Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Clinical trial NCT01618305 · COMPLETED
Trial details
- NCT number
- NCT01618305
- Sponsor
- Westat
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-05
- Primary completion
- 2018-12-11
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.